Caliban's heritance and the genetics of neuronal aging

Trends in Neurosciences

Volumn 27, Issue 10, 2004, Pages 627-632

  Teter, Bruce ^a   Finch, Caleb E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ALLELE; ALZHEIMER DISEASE; ASTROCYTE; BIOACCUMULATION; BRAIN; CELL AGING; CELL LOSS; CHROMOSOME; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENETIC MODEL; GENOTYPE; HUMAN; NERVE CELL; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RODENT; TRANSGENE;

AGING; ANIMALS; APOLIPOPROTEINS E; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; MODELS, ANIMAL; NEURODEGENERATIVE DISEASES; NEURONS; PEPTIDE FRAGMENTS;

EID: 4544233053     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2004.08.005     Document Type: Review

References (70)

1. M.J. West Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease Lancet 344 1994 769 772
2. C.E. Finch Neuron atrophy during aging: programmed or sporadic? Trends Neurosci. 16 1993 104 110
3. Rozovsky, I. et al. Reversible age impairments in neurite outgrowth by manipulations of astrocytic GFAP. Neurobiol. Aging (in press)
4. S. Reeves Ageing and the nigrostriatal dopaminergic system Int. J. Geriatr. Psychiatry 17 2002 359 370
5. M. Inoue Age-related reduction of extra striatal dopamine D2 receptor measured by PET Life Sci. 69 2001 1079 1084
6. D.E. Smith Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy Proc. Natl. Acad. Sci. U. S. A. 96 1999 10893 10898
7. D.M. Holtzman Nerve growth factor reverses neuronal atrophy in a Down syndrome model of age-related neurodegeneration Neurology 43 1993 2668 2673
8. C.E. Finch Microglia and aging in the brain W.J. Streit Microglia in the Regenerating and Degenerating Central Nervous System 2002 Springer-Verlag 275 305
9. R.D. Monagle, and H. Brody The effects of age upon the main nucleus of the inferior olive in the human J. Comp. Neurol. 155 1974 61 66
10. G.E. McClearn Nature and nurture: interaction and coaction Am. J. Med. Genet. 124B 2004 124 130
11. P.M. Greenwood, and R. Parasuraman Normal genetic variation, cognition, and aging Behav. Cogn. Neurosci. Rev. 2 2003 278 306
12. L. Bertram, and R.E. Tanzi Alzheimer's disease: one disorder, too many genes? Hum. Mol. Genet. 13 2004 R135 R141
13. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol. (Berl.) 82 1991 239 259
14. T. Arai A high incidence of apolipoprotein E epsilon4 allele in middle-aged non-demented subjects with cerebral amyloid beta protein deposits Acta Neuropathol. (Berl.) 97 1999 82 84
15. B. Caughey, and P.T. Lansbury Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders Annu. Rev. Neurosci. 26 2003 267 298
16. W.L. Klein Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24 2001 219 224
17. R.H. Takahashi Oligomerization of Alzheimer's β-amyloid within processes and synapses of cultured neurons and brain J. Neurosci. 24 2004 3592 3599
18. T.A. Lanz Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype Neurobiol. Dis. 13 2003 246 253
19. L. Mucke High-level neuronal expression of Aβ 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation J. Neurosci. 20 2000 4050 4058
20. D.W. Dickson Building a more perfect beast: APP transgenic mice with neuronal loss Am. J. Pathol. 164 2004 1143 1146
21. W.L. Lin Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau J. Neurocytol. 32 2003 1091 1105
22. B. Teter, and J.W. Ashford Neuroplasticity in Alzheimer's disease J. Neurosci. Res. 70 2002 402 437
23. T. Arendt Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein ε4 allele J. Neurosci. 17 1997 516 529
24. B. Teter Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture J. Neurochem. 73 1999 2613 2616
25. B. Teter Defective neuronal sprouting supported by human Apolipoprotein E4 represents a gain-of-deleterious function J. Neurosci. Res. 68 2002 331 336
26. A.S. Khachaturian Apolipoprotein E ε4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study Arch. Gen. Psychiatry 61 2004 518 524
27. Y. Ji Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients Neuroscience 122 2003 305 315
28. E.J. Dubelaar ApoE epsilon4 genotype is accompanied by lower metabolic activity in nucleus basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size of the Golgi apparatus J. Neuropathol. Exp. Neurol. 63 2004 159 169
29. G.B. Frisoni Longevity and the ε2 allele of apolipoprotein E: the Finnish Centenarians Study J. Gerontol. A Biol. Sci. Med. Sci. 56 2001 M75 M78
30. J. Kaprio Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease Arterioscler. Thromb. 11 1991 1330 1348
31. T.A. Prolla, and M.P. Mattson Molecular mechanisms of brain aging and neurodegenerative disorders: lessons from dietary restriction Trends Neurosci. 24 2001 S21 S31
32. J.L. Kennedy The genetics of adult-onset neuropsychiatric disease: complexities and conundra? Science 302 2003 822 826
33. D. Turic No association between apolipoprotein E polymorphisms and general cognitive ability in children Neurosci. Lett. 299 2001 97 100
34. I.J. Deary Cognitive change and the APOE ε4 allele Nature 418 2002 932
35. K.P. Riley Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study J. Gerontol. B Psychol. Sci. Soc. Sci. 55 2000 S69 S75
36. T.G. Ohm Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation Neuroscience 66 1995 583 587
37. E.M. Reiman Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia Proc. Natl. Acad. Sci. U. S. A. 101 2004 284 289
38. G.W. Small Use of neuroimaging to detect early brain changes in people at genetic risk for Alzheimer's disease Adv. Drug Deliv. Rev. 54 2002 1561 1566
39. Greenwood, P.M. et al. Effects of APOE genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: Results from the NIMH BIOCARD study. Neuropsychology (in press)
40. R.M. Cohen Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women Neurology 57 2001 2223 2228
41. M.W. Bondi Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease Psychol. Aging 14 1999 295 303
42. W.P. Goldman Absence of cognitive impairment or decline in preclinical Alzheimer's disease Neurology 56 2001 361 367
43. O.L. Lopez Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2 Arch. Neurol. 60 2003 1394 1399
44. M.A. Boss Diagnostic approaches to Alzheimer's disease Biochim. Biophys. Acta 1502 2000 188 200
45. L.M. Ercoli MMSE items predict cognitive decline in persons with genetic risk for Alzheimer's disease J. Geriatr. Psychiatry Neurol. 16 2003 67 73
46. N.L. Pedersen How heritable is Alzheimer's disease late in life? Findings from Swedish twins Ann. Neurol. 55 2004 180 185
47. P-T. Xu Human apolipoprotein E2, E3 and E4 isoform specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild type mice Neurobiol. Dis. 3 1996 229 245
48. S. Fazio, and M.F. Linton Mouse models of hyperlipidemia and atherosclerosis Front. Biosci. 6 2001 D515 D525
49. M. Michikawa Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer's disease? J. Neurosci. Res. 72 2003 141 146
50. J.R. Lynch APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response J. Biol. Chem. 278 2003 48529 48533
51. R.E. Hartman Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology Exp. Neurol. 170 2001 326 344
52. J. Raber Apolipoprotein E and cognitive performance Nature 404 2000 352 353
53. W.J. Brecht Neuron-specific apolipoprotein ε4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice J. Neurosci. 24 2004 2527 2534
54. M. Buttini Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation J. Neurosci. 22 2002 10539 10548
55. A.M. Fagan Human and murine ApoE markedly alters Aβ metabolism before and after plaque formation in a mouse model of Alzheimer's disease Neurobiol. Dis. 9 2002 305 318
56. C.E. Finch, and C.B. Stanford Meat-adaptive genes and the evolution of slower aging in humans Q. Rev. Biol. 79 2004 3 50
57. S.M. Fullerton Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism Am. J. Hum. Genet. 67 2000 881 900
58. G.M. Martin APOE alleles and lipophylic pathogens Neurobiol. Aging 20 1999 441 443
59. M.A. Wozniak Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus Hepatology 36 2002 456 463
60. A. Ebel Genotypic differences in central neurotransmitter responses to aging in mice Neurobiol. Aging 8 1987 417 427
61. J.M. Harper Quantitative trait loci for insulin-like growth factor I, leptin, thyroxine, and corticosterone in genetically heterogeneous mice Physiol. Genomics 15 2003 44 51
62. T. Takeda Senescence-accelerated mouse (SAM): a biogerontological resource in aging research Neurobiol. Aging 20 1999 105 110
63. T. Kawamata Age-related changes in the brains of senescence-accelerated mice (SAM): association with glial and endothelial reactions Microsc. Res. Tech. 43 1998 59 67
64. A. Shimada Age-related loss of synapses in the frontal cortex of SAMP10 mouse: a model of cerebral degeneration Synapse 48 2003 198 204
65. S.J. Jeong Age-related changes in the expression of Alzheimer's βAPP in the brain of senescence accelerated mouse (SAM)-P/10 Neuroreport 8 1997 1733 1737
66. M. Jucker Age-related fibrillar deposits in brains of C57BL/6 mice. A review of localization, staining characteristics, and strain specificity Mol. Neurobiol. 9 1994 125 133
67. X. Ye The occurrence of vacuolation, and periodic acid-Schiff (PAS)-positive granules and plaques in the brains of C57BL/6J, AKR, senescence-prone (SAMP8) and senescence-resistant (SAMR1) mice infected with various scrapie strains Brain Res. 995 2004 158 166
68. B.A. Kinney-Forshee Could a deficiency in growth hormone signaling be beneficial to the aging brain? Physiol. Behav. 80 2004 589 594
69. K. Flurkey Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production Proc. Natl. Acad. Sci. U. S. A. 98 2001 6736 6741
70. J.M. Shulman, and M.B. Feany Genetic modifiers of tauopathy in Drosophila Genetics 165 2003 1233 1242